08:00 , Jan 8, 2009 |  BC Innovations  |  Targets & Mechanisms

Gazing deeper into cancer

Three recent genomic studies in glioblastoma multiforme, 1 acute myeloid leukemia 2 and lung adenocarcinoma 3 reveal potential new drug targets and provide a next step toward personalized, whole genome-based cancer diagnostics. Genomic sequencing could...
00:44 , Jun 2, 2007 |  BC Extra  |  Clinical News

EphB4 increases proangiogenic potential of EPCs

Researchers from Institut des Vaisseaux et du Sang in Paris and colleagues reported in The Journal of Clinical Investigation that EphB4 increases the proangiogenic potential of endothelial progenitor cells (EPCs). They noted that while EPC...